JP5179583B2 - 時間分割アンペロメトリを用いる被分析物濃度の測定システム及び測定方法 - Google Patents
時間分割アンペロメトリを用いる被分析物濃度の測定システム及び測定方法 Download PDFInfo
- Publication number
- JP5179583B2 JP5179583B2 JP2010518403A JP2010518403A JP5179583B2 JP 5179583 B2 JP5179583 B2 JP 5179583B2 JP 2010518403 A JP2010518403 A JP 2010518403A JP 2010518403 A JP2010518403 A JP 2010518403A JP 5179583 B2 JP5179583 B2 JP 5179583B2
- Authority
- JP
- Japan
- Prior art keywords
- analyte
- current
- time segment
- analyte concentration
- calibration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 169
- 238000000034 method Methods 0.000 title claims abstract description 77
- 238000005259 measurement Methods 0.000 title description 50
- 238000004082 amperometric method Methods 0.000 title description 3
- 238000011088 calibration curve Methods 0.000 claims abstract description 69
- 230000005284 excitation Effects 0.000 claims abstract description 34
- 238000012360 testing method Methods 0.000 claims description 116
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 71
- 239000008103 glucose Substances 0.000 claims description 71
- 238000005534 hematocrit Methods 0.000 claims description 57
- 210000004369 blood Anatomy 0.000 claims description 44
- 239000008280 blood Substances 0.000 claims description 44
- 239000007788 liquid Substances 0.000 claims description 38
- 238000004458 analytical method Methods 0.000 claims description 16
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 229940088598 enzyme Drugs 0.000 claims description 7
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 6
- 239000004366 Glucose oxidase Substances 0.000 claims description 5
- 108010015776 Glucose oxidase Proteins 0.000 claims description 5
- 229940116332 glucose oxidase Drugs 0.000 claims description 5
- 235000019420 glucose oxidase Nutrition 0.000 claims description 5
- -1 potassium ferricyanide Chemical compound 0.000 claims description 5
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 239000012530 fluid Substances 0.000 abstract description 4
- 239000010410 layer Substances 0.000 description 34
- 239000003153 chemical reaction reagent Substances 0.000 description 18
- 239000000306 component Substances 0.000 description 17
- 239000000243 solution Substances 0.000 description 14
- 230000000875 corresponding effect Effects 0.000 description 10
- 210000003743 erythrocyte Anatomy 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 238000005070 sampling Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 238000004422 calculation algorithm Methods 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000013213 extrapolation Methods 0.000 description 6
- 125000006850 spacer group Chemical group 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000002411 adverse Effects 0.000 description 4
- 239000012503 blood component Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000004020 conductor Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 239000012790 adhesive layer Substances 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000027756 respiratory electron transport chain Effects 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000012292 cell migration Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000000840 electrochemical analysis Methods 0.000 description 2
- 238000003487 electrochemical reaction Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000012067 mathematical method Methods 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 description 2
- 235000011009 potassium phosphates Nutrition 0.000 description 2
- 238000006479 redox reaction Methods 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- NECRQCBKTGZNMH-UHFFFAOYSA-N 3,5-dimethylhex-1-yn-3-ol Chemical compound CC(C)CC(C)(O)C#C NECRQCBKTGZNMH-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000016222 Pancreatic disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 108010074506 Transfer Factor Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000002210 biocatalytic effect Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000003977 dairy farming Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010292 electrical insulation Methods 0.000 description 1
- 239000012777 electrically insulating material Substances 0.000 description 1
- 238000006056 electrooxidation reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 208000024691 pancreas disease Diseases 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
- G01N27/3273—Devices therefor, e.g. test element readers, circuitry
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95207607P | 2007-07-26 | 2007-07-26 | |
| US60/952,076 | 2007-07-26 | ||
| PCT/US2008/071132 WO2009015319A1 (en) | 2007-07-26 | 2008-07-25 | System and methods for determination of analyte concentration using time resolved amperometry |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010534839A JP2010534839A (ja) | 2010-11-11 |
| JP2010534839A5 JP2010534839A5 (OSRAM) | 2011-09-08 |
| JP5179583B2 true JP5179583B2 (ja) | 2013-04-10 |
Family
ID=39951498
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010518403A Active JP5179583B2 (ja) | 2007-07-26 | 2008-07-25 | 時間分割アンペロメトリを用いる被分析物濃度の測定システム及び測定方法 |
| JP2010518401A Active JP5604298B2 (ja) | 2007-07-26 | 2008-07-25 | 時間分解電流測定法を用いて被分析物の濃度を測定する方法及びシステム |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010518401A Active JP5604298B2 (ja) | 2007-07-26 | 2008-07-25 | 時間分解電流測定法を用いて被分析物の濃度を測定する方法及びシステム |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20090076738A1 (OSRAM) |
| EP (2) | EP2176653B1 (OSRAM) |
| JP (2) | JP5179583B2 (OSRAM) |
| AT (1) | ATE523777T1 (OSRAM) |
| AU (2) | AU2008279070B2 (OSRAM) |
| BR (2) | BRPI0814201A2 (OSRAM) |
| MX (3) | MX2010000971A (OSRAM) |
| TW (2) | TWI453401B (OSRAM) |
| WO (2) | WO2009015316A1 (OSRAM) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2553632A1 (en) | 2004-02-06 | 2005-08-25 | Bayer Healthcare Llc | Oxidizable species as an internal reference for biosensors and method of use |
| EP3483598B1 (en) | 2005-09-30 | 2024-11-06 | Ascensia Diabetes Care Holdings AG | Gated voltammetry |
| TWI453401B (zh) * | 2007-07-26 | 2014-09-21 | Nipro Diagnostics Inc | 使用時間解析電流測定法之用於分析物濃度測定的系統及方法（一） |
| US8101062B2 (en) * | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
| EP2222867B1 (en) * | 2007-12-10 | 2018-07-11 | Ascensia Diabetes Care Holdings AG | Rapid-read gated amperometry |
| WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
| JP2009272996A (ja) * | 2008-05-09 | 2009-11-19 | Toshiba Corp | 携帯端末 |
| US8262899B2 (en) | 2008-07-10 | 2012-09-11 | Bayer Healthcare Llc | Systems and methods including amperometric and voltammetric duty cycles |
| ATE546730T1 (de) * | 2008-11-26 | 2012-03-15 | Atotech Deutschland Gmbh | Verfahren zur kontrolle von stabilisatoradditiven in elektrolyten zur chemischen metall- und metalllegierungsabscheidung |
| JP2010261895A (ja) * | 2009-05-11 | 2010-11-18 | Emiko Kaneko | 溶液中微量成分の濃度測定方法及び濃度測定装置 |
| US8173008B2 (en) * | 2009-06-24 | 2012-05-08 | Lifescan, Inc. | Method for determining an analyte in a bodily fluid sample using an analyte test strip with combination electrode contact and meter identification feature |
| US20100326824A1 (en) * | 2009-06-24 | 2010-12-30 | Lifescan, Inc. | Analyte test strip with combination electrode contact and meter identification feature |
| US8877034B2 (en) * | 2009-12-30 | 2014-11-04 | Lifescan, Inc. | Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity |
| US8101065B2 (en) | 2009-12-30 | 2012-01-24 | Lifescan, Inc. | Systems, devices, and methods for improving accuracy of biosensors using fill time |
| KR101929057B1 (ko) * | 2010-03-22 | 2018-12-13 | 바이엘 헬쓰케어 엘엘씨 | 바이오센서를 위한 잔여 보상 |
| EP2565636A3 (en) * | 2010-03-31 | 2013-04-03 | Lifescan Scotland Limited | Electrochemical analyte measurement method and system |
| WO2012035297A1 (en) * | 2010-09-13 | 2012-03-22 | Lifescan Scotland Limited | Analyte measurement method and system with hematocrit compensation |
| US8932445B2 (en) | 2010-09-30 | 2015-01-13 | Cilag Gmbh International | Systems and methods for improved stability of electrochemical sensors |
| US8617370B2 (en) | 2010-09-30 | 2013-12-31 | Cilag Gmbh International | Systems and methods of discriminating between a control sample and a test fluid using capacitance |
| WO2012084194A1 (en) | 2010-12-22 | 2012-06-28 | Roche Diagnostics Gmbh | Systems and methods to compensate for sources of error during electrochemical testing |
| WO2012142536A2 (en) * | 2011-04-14 | 2012-10-18 | Bayer Healthcare Llc | Detection of contamination at sensor contacts |
| US9775806B2 (en) | 2011-09-21 | 2017-10-03 | Ascensia Diabetes Care Holdings Ag | Analysis compensation including segmented signals |
| US8534115B2 (en) * | 2011-10-17 | 2013-09-17 | Schlumberger Technology Corporation | Systems and methods of determining parameter values in a downhole environment |
| US9636044B2 (en) * | 2012-02-01 | 2017-05-02 | Invoy Technologies, Llc | Breath analyzer with expandable range of measurement |
| WO2014100428A1 (en) * | 2012-12-20 | 2014-06-26 | Becton, Dickinson And Company | System and method for using multiple sensor calibration methods |
| GB201511299D0 (en) * | 2015-06-26 | 2015-08-12 | Inside Biometrics Ltd | Test device and method of using a test device |
| WO2019036586A1 (en) * | 2017-08-18 | 2019-02-21 | Diversey, Inc. | Solution concentration sensing devices |
| CN111683592B (zh) * | 2017-10-30 | 2023-11-03 | 加利福尼亚大学董事会 | 使用电化学传感器对分析物进行无校正的体内测量 |
| US20240389890A1 (en) * | 2021-09-27 | 2024-11-28 | Medtrum Technologies Inc. | Analyte detection system |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6279159U (OSRAM) * | 1985-11-07 | 1987-05-20 | ||
| JPH0672845B2 (ja) * | 1986-09-01 | 1994-09-14 | 富士写真フイルム株式会社 | 分析方法 |
| US5352351A (en) * | 1993-06-08 | 1994-10-04 | Boehringer Mannheim Corporation | Biosensing meter with fail/safe procedures to prevent erroneous indications |
| US6153069A (en) * | 1995-02-09 | 2000-11-28 | Tall Oak Ventures | Apparatus for amperometric Diagnostic analysis |
| AUPN661995A0 (en) * | 1995-11-16 | 1995-12-07 | Memtec America Corporation | Electrochemical cell 2 |
| JPH09292387A (ja) * | 1996-04-25 | 1997-11-11 | Kdk Corp | 被測定成分量の測定方法及び被測定成分量の測定装置 |
| US5997817A (en) * | 1997-12-05 | 1999-12-07 | Roche Diagnostics Corporation | Electrochemical biosensor test strip |
| US6251260B1 (en) * | 1998-08-24 | 2001-06-26 | Therasense, Inc. | Potentiometric sensors for analytic determination |
| US6475372B1 (en) * | 2000-02-02 | 2002-11-05 | Lifescan, Inc. | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
| US6424847B1 (en) * | 1999-02-25 | 2002-07-23 | Medtronic Minimed, Inc. | Glucose monitor calibration methods |
| US7276146B2 (en) * | 2001-11-16 | 2007-10-02 | Roche Diagnostics Operations, Inc. | Electrodes, methods, apparatuses comprising micro-electrode arrays |
| US20060091006A1 (en) * | 1999-11-04 | 2006-05-04 | Yi Wang | Analyte sensor with insertion monitor, and methods |
| EP2388587B1 (en) | 2000-11-30 | 2018-01-10 | Panasonic Healthcare Holdings Co., Ltd. | Method of quantifying substrate |
| WO2003000127A2 (en) | 2001-06-22 | 2003-01-03 | Cygnus, Inc. | Method for improving the performance of an analyte monitoring system |
| WO2003036285A1 (en) * | 2001-10-26 | 2003-05-01 | Arkray, Inc. | Specific component concentration measuring method and concentration measuring instrument |
| US7018843B2 (en) * | 2001-11-07 | 2006-03-28 | Roche Diagnostics Operations, Inc. | Instrument |
| KR100475634B1 (ko) * | 2001-12-24 | 2005-03-15 | 주식회사 아이센스 | 일정 소량의 시료를 빠르게 도입할 수 있는 시료도입부를구비한 바이오 센서 |
| US6863800B2 (en) * | 2002-02-01 | 2005-03-08 | Abbott Laboratories | Electrochemical biosensor strip for analysis of liquid samples |
| ATE507766T1 (de) | 2002-03-22 | 2011-05-15 | Animas Technologies Llc | Leistungsverbesserung einer analytenüberwachungsvorrichtung |
| KR100729307B1 (ko) | 2002-06-17 | 2007-06-15 | 아크레이 인코퍼레이티드 | 글루코스 탈수소효소를 이용한 글루코스 농도 측정방법 및글루코스 센서 |
| JP4341032B2 (ja) * | 2002-11-01 | 2009-10-07 | アークレイ株式会社 | 固体成分濃縮手段を備えた測定用具 |
| MX2008002056A (es) * | 2005-08-16 | 2008-04-19 | Home Diagnostics Inc | Metodo para la fabricacion de una tira de prueba y analisis de una tarjeta de prueba. |
| ES2535657T3 (es) * | 2005-09-14 | 2015-05-13 | Sumitomo Electric Industries, Ltd. | Dispositivo de medición por biosensor, sistema de medición por biosensor, y método de medición por biosensor |
| US7749371B2 (en) * | 2005-09-30 | 2010-07-06 | Lifescan, Inc. | Method and apparatus for rapid electrochemical analysis |
| US20080020452A1 (en) * | 2006-07-18 | 2008-01-24 | Natasha Popovich | Diagnostic strip coding system with conductive layers |
| US7822557B2 (en) | 2006-10-31 | 2010-10-26 | Abbott Diabetes Care Inc. | Analyte sensors and methods |
| US20090007947A1 (en) * | 2006-12-22 | 2009-01-08 | Angela Spangenberg | Portable weather shielding canopy |
| US20090026094A1 (en) * | 2007-05-11 | 2009-01-29 | Home Diagnostics, Inc. | Two-pulse systems and methods for determining analyte concentration |
| TWI453401B (zh) | 2007-07-26 | 2014-09-21 | Nipro Diagnostics Inc | 使用時間解析電流測定法之用於分析物濃度測定的系統及方法（一） |
| US8101062B2 (en) * | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
-
2008
- 2008-07-25 TW TW097128393A patent/TWI453401B/zh active
- 2008-07-25 AU AU2008279070A patent/AU2008279070B2/en not_active Expired - Fee Related
- 2008-07-25 MX MX2010000971A patent/MX2010000971A/es active IP Right Grant
- 2008-07-25 WO PCT/US2008/071128 patent/WO2009015316A1/en not_active Ceased
- 2008-07-25 BR BRPI0814201-7A2A patent/BRPI0814201A2/pt active Search and Examination
- 2008-07-25 MX MX2010000972A patent/MX2010000972A/es not_active Application Discontinuation
- 2008-07-25 WO PCT/US2008/071132 patent/WO2009015319A1/en not_active Ceased
- 2008-07-25 JP JP2010518403A patent/JP5179583B2/ja active Active
- 2008-07-25 JP JP2010518401A patent/JP5604298B2/ja active Active
- 2008-07-25 BR BRPI0814202-5A patent/BRPI0814202B1/pt active IP Right Grant
- 2008-07-25 AT AT08796603T patent/ATE523777T1/de not_active IP Right Cessation
- 2008-07-25 TW TW097128397A patent/TW200916774A/zh unknown
- 2008-07-25 US US12/179,870 patent/US20090076738A1/en not_active Abandoned
- 2008-07-25 AU AU2008279067A patent/AU2008279067A1/en not_active Abandoned
- 2008-07-25 EP EP08796603A patent/EP2176653B1/en not_active Not-in-force
- 2008-07-25 EP EP08796601.6A patent/EP2176652B1/en active Active
- 2008-07-25 US US12/179,853 patent/US8088272B2/en active Active
-
2010
- 2010-01-25 MX MX2013002928A patent/MX340856B/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009015319A1 (en) | 2009-01-29 |
| EP2176652A1 (en) | 2010-04-21 |
| TW200916774A (en) | 2009-04-16 |
| US8088272B2 (en) | 2012-01-03 |
| EP2176653A1 (en) | 2010-04-21 |
| BRPI0814201A2 (pt) | 2015-01-27 |
| JP2010534839A (ja) | 2010-11-11 |
| ATE523777T1 (de) | 2011-09-15 |
| MX2010000972A (es) | 2010-03-01 |
| US20090101523A1 (en) | 2009-04-23 |
| BRPI0814202A2 (pt) | 2015-01-27 |
| EP2176653B1 (en) | 2011-09-07 |
| EP2176652B1 (en) | 2014-04-23 |
| AU2008279070B2 (en) | 2012-12-13 |
| US20090076738A1 (en) | 2009-03-19 |
| MX2010000971A (es) | 2010-03-01 |
| AU2008279070A1 (en) | 2009-01-29 |
| WO2009015316A1 (en) | 2009-01-29 |
| AU2008279067A1 (en) | 2009-01-29 |
| TWI453401B (zh) | 2014-09-21 |
| JP5604298B2 (ja) | 2014-10-08 |
| TW200914820A (en) | 2009-04-01 |
| MX340856B (es) | 2016-07-28 |
| JP2010534838A (ja) | 2010-11-11 |
| BRPI0814202B1 (pt) | 2019-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5179583B2 (ja) | 時間分割アンペロメトリを用いる被分析物濃度の測定システム及び測定方法 | |
| AU2010229211B2 (en) | System and methods for determination of analyte concentration using time resolved amperometry | |
| US20090026094A1 (en) | Two-pulse systems and methods for determining analyte concentration | |
| US20120111739A1 (en) | Dual Frequency Impedance Measurement of Hematocrit in Strips | |
| JP6184322B2 (ja) | 電気化学センサの安定性改善のためのシステムおよび方法 | |
| EP2473847B1 (en) | Glucose measurement method and system | |
| US20130220836A1 (en) | System and method for measuring an analyte in a sample | |
| US9709521B2 (en) | System and method for measuring an analyte in a sample and correcting for interferents | |
| US11035819B2 (en) | Method for determining analyte concentration in a sample technical field | |
| JP2022542576A (ja) | 試料の分析物濃度を決定するための方法 | |
| HK1146302B (en) | Rapid-read gated amperometry | |
| HK1243163B (zh) | 确定分析物浓度的测量装置、生物传感器系统和方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20101027 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20101027 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110722 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110722 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120828 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120830 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121114 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121211 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130109 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5179583 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |